Your browser doesn't support javascript.
loading
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study.
Bizzotto, Roberto; Jennison, Christopher; Jones, Angus G; Kurbasic, Azra; Tura, Andrea; Kennedy, Gwen; Bell, Jimmy D; Thomas, E Louise; Frost, Gary; Eriksen, Rebeca; Koivula, Robert W; Brage, Soren; Kaye, Jane; Hattersley, Andrew T; Heggie, Alison; McEvoy, Donna; 't Hart, Leen M; Beulens, Joline W; Elders, Petra; Musholt, Petra B; Ridderstråle, Martin; Hansen, Tue H; Allin, Kristine H; Hansen, Torben; Vestergaard, Henrik; Lundgaard, Agnete T; Thomsen, Henrik S; De Masi, Federico; Tsirigos, Konstantinos D; Brunak, Søren; Viñuela, Ana; Mahajan, Anubha; McDonald, Timothy J; Kokkola, Tarja; Forgie, Ian M; Giordano, Giuseppe N; Pavo, Imre; Ruetten, Hartmut; Dermitzakis, Emmanouil; McCarthy, Mark I; Pedersen, Oluf; Schwenk, Jochen M; Adamski, Jerzy; Franks, Paul W; Walker, Mark; Pearson, Ewan R; Mari, Andrea.
Afiliación
  • Bizzotto R; CNR Institute of Neuroscience, Padova, Italy roberto.bizzotto@cnr.it.
  • Jennison C; Department of Mathematical Sciences, University of Bath, Bath, U.K.
  • Jones AG; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • Kurbasic A; Diabetes and Endocrinology, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
  • Tura A; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Malmö, Malmö, Sweden.
  • Kennedy G; CNR Institute of Neuroscience, Padova, Italy.
  • Bell JD; Immunoassay Biomarker Core Laboratory, School of Medicine, Ninewells Hospital, Dundee, U.K.
  • Thomas EL; School of Life Sciences, Research Centre for Optimal Health, University of Westminster, London, U.K.
  • Frost G; School of Life Sciences, Research Centre for Optimal Health, University of Westminster, London, U.K.
  • Eriksen R; Section for Nutrition Research, Faculty of Medicine, Hammersmith Campus, Imperial College London, London, U.K.
  • Koivula RW; Section for Nutrition Research, Faculty of Medicine, Hammersmith Campus, Imperial College London, London, U.K.
  • Brage S; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Malmö, Malmö, Sweden.
  • Kaye J; Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
  • Hattersley AT; MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Heggie A; Faculty of Law, Centre for Health, Law and Emerging Technologies, University of Oxford, Oxford, U.K.
  • McEvoy D; Melbourne Law School, Centre for Health, Law and Emerging Technologies, University of Melbourne, Carlton, Victoria, Australia.
  • 't Hart LM; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • Beulens JW; Diabetes and Endocrinology, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
  • Elders P; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K.
  • Musholt PB; Diabetes Research Network, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
  • Ridderstråle M; Department of Epidemiology and Data Science, Amsterdam UMC-Location VUmc, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Hansen TH; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Allin KH; Department of Biomedical Data Sciences, Molecular Epidemiology Section, Leiden University Medical Center, Leiden, the Netherlands.
  • Hansen T; Department of Epidemiology and Data Science, Amsterdam UMC-Location VUmc, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Vestergaard H; Department of General Practice, Amsterdam UMC-Location VUmc, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Lundgaard AT; R&D Global Development, Translational Medicine & Clinical Pharmacology, Sanofi Deutschland GmbH, Frankfurt, Germany.
  • Thomsen HS; Clinical Pharmacology and Translational Medicine, Novo Nordisk A/S, Søborg, Denmark.
  • De Masi F; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Tsirigos KD; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Brunak S; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Viñuela A; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mahajan A; Bornholms Hospital, Rønne, Denmark.
  • McDonald TJ; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Kokkola T; Department of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Forgie IM; Faculty of Medical and Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Giordano GN; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Pavo I; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Ruetten H; Department of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Dermitzakis E; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • McCarthy MI; Department of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Pedersen O; Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
  • Schwenk JM; Faculty of Medical Sciences, Biosciences Institute, Newcastle University, Newcastle, U.K.
  • Adamski J; Wellcome Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Franks PW; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • Walker M; Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
  • Pearson ER; Department of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Mari A; Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
Diabetes Care ; 44(2): 511-518, 2021 02.
Article en En | MEDLINE | ID: mdl-33323478
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Límite: Humans Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Límite: Humans Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos